Skip to main content
. 2016 Nov 18;20:373. doi: 10.1186/s13054-016-1548-2

Table 2.

Laboratory findings and echocardiography index at admission in patients with sepsis and different AF status

Overall patients (n = 503) P value
No NeOAF (n = 263) NeOAF to SR (n = 165) NeOAF to AF (n = 75)
Laboratory
 WBC (×103/L) 13.47 ± 8.73 13.43 ± 7.23 15.39 ± 11.73 0.22
 CRP (mmol/L) 12.8 ± 10.9 10.0 ± 9.9† 11.2 ± 8.5 0.02
 Na+ (mmol/L) 135.6 ± 8.5 135.7 ± 10.1 136.7 ± 7.8 0.64
 K+ (mmol/L) 4.1 ± 1.0 4.2 ± 1.0 4.1 ± 0.9 0.46
 Free Ca2+ (mmol/L) 4.23 ± 0.31 4.35 ± 0.46 4.17 ± 0.68 0.46
 Albumin (g/dL) 2.7 ± 0.6 2.7 ± 0.6 2.6 ± 0.6 0.37
 BNP (pg/ml) 918.6 ± 1152.2 1131.3 ± 1325.6 1102.4 ± 1418.1 0.58
 Tr-I (ng/ml) 1.09 ± 5.92 1.98 ± 5.95 3.71 ± 13.42a 0.04
Echocardiography
 LAD (mm) 36.5 ± 7.4 38.4 ± 7.2† 40.5 ± 7.2a <0.01
 LVEDD (mm3) 45.7 ± 8.0 46.1 ± 7.7 46.6 ± 7.5 0.73
 LVESD (mm3) 30.3 ± 8.0 30.9 ± 7.3 32.3 ± 8.4 0.22
 LVEF < 50%, n (%) 31 (13.7) 29 (18.2) 18 (27.7)† 0.03

NeOAF new-onset atrial fibrillation, AF atrial fibrillation, SR sinus rhythm, WBC white blood cell count, CRP C-reactive protein, BNP B-type natriuretic peptide, Tr-I troponin I, LAD left atrium diameter, LVEDD left ventricular end diastolic diameter, LVESD left ventricular end systolic diameter, LVEF left ventricular ejection fraction. a P < 0.05 vs. no NeOAF